Index
infections
(Continued)
skin, 502-503
vagina, 279
vulva, 274
infectious mononucleosis (IM ), 678
inflam m ation, 92,
93
breast, inflam m atory carcinoma of, 750
breast lesions, 718
cervix, 147-150
changes in, 95
chronic inflam m atory bowel disease, 398
effusions, 535-536
specific inflam m ation, 536-540
eye, 463-464
and human papillomavirus, 112
kidney disorders, 814
myofibroblastic inflam m atory bladder
tumor, 943
pseudotumor, inflammatory, 920-921
salivary glands, inflam m atory lesions of,
609-610
urinary tract, 414-415
vagina, 279
vulva, 274
INRAD needles, 580
insulin-like growth factor 1 (IGF1), 37
interference contrast microscopy, 1005
interferon therapy, 431, 961-962
intermediate filaments, cytoskeleton, 8, 135,
136
International Agency for Research on Cancer
(IARC), working group, 49
International Committee on Histological
Terminology for Lesions o f the Uterine
Cervix (Vienna, 1961), 173
International Federation o f Gynecology and
Obstetrics (FIGO), 185,
190
,
251
International Society for Vulvovaginal
Diseases (ISSVD), 276
interobserver reproducibility, cervical
cytology, 87
interphase period, mitosis, 24
intestines
large
see
large intestine
pediatric tumors, 924
intracystic carcinoma, breast, 746,
749
intraductal carcinoma, breast, 739, 741,
744
intraductal papillary mucinous neoplasm,
pancreas, 901-902
intraductal papilloma, breast, 730
intraepithelial neoplasia, cervical
see also
dysplasia
intrahepatic bile duct
bile duct adenoma, 891,
892
cholangiocarcinomas, 891-892,
893
intramuscular myxoma, 486
intraocular washing
see
vitrectomy
(intraocular washing)
intraventricular shunts, reactions to,
443-444
invasive cancer
see also
cancer
cervix
see
invasive cervical cancer
urothelial carcinoma, 422-424
invasive cervical cancer, 184-201
adenosquamous carcinoma, 195,
196
age at detection, 189
cell arrangement, 191
cell size and shape, 191
invasive cervical cancer
(Continued)
clinical considerations, 190
concept, 131
cytology, 191-192
grading, 190
histology, 190-191
immunocytochemistry, 197-199
keratinizing, 190, 191, 192-193,
194, 195
Ki-67, 199
microinvasive carcinoma
see
microinvasive
carcinoma
nuclear morphology, 187
non-keratinizing, 191, 192
nonkeratizing, 191-192
nuclear morphology, 187, 191
p16, oncoprotein, 199, 1058, 1061
relative nuclear area, 191
small-cell, 195-196,
197
verrucous carcinoma, 193, 195
iodine, thyroid-suppressive therapy, 966
ionizing radiation
see
radiation biology
ionotropic and non-ionotropic receptors, cell
membrane, 9
iron hematoxylin, mitochondria, 8
ISH (in situ hybridization)
and human papillomavirus, 116
principle, 26
tyramade-amplified, 1083
islet cells, pancreas, 897
ISSVD (International Society for Vulvovaginal
Diseases), 276
IUDs (intrauterine contraceptive devices)
Actinomyces
infection, 101
cells/cellular changes, 102-103,
105
glandular cell lesions, 234,
236
reactive and regenerative changes, 150
therapy, 968
J
Joint Commission for Accreditation of Health
Care Organizations (JACHO), safety
guidelines, 584
juvenile granulosa cell tumors, 298
juvenile hemangiomas, 483-484
juvenile lymphocytic thyroiditis, 639
juvenile papillomatosis, 727
juvenile xanthogranuloma (FNA OW), 459
juxtaglomerular cell tumor, 838,
839
K
Kaposi sarcoma, 484
karyopyknotic index, 955
karyotype/karyotyping
see also
chromosomes
banding analysis, 25-26,
28
complex karyotypic abnormalities,
sarcomas, 37-38
development of, 25
Ewing's tumor,
36
mantle cell lymphomas, 31
marginal zone B-cell lymphomas,
32
near-tetraploid, mantle cell lymphoma, 31
simple karyotypic abnormalities, sarcomas,
35-37
synovial sarcoma,
37
Kawasaki's disease (mucocutaneous lymph
node syndrome), 417
keratins, intermediate filaments, 8, 135, 136,
138
key-lock principle, receptors, 9
Ki-67, oncoprotein, 199, 201, 1066
kidney cancer
see also
renal pelvis/renal pelvis tumors
adenocarcinoma, 425,
426
Birt-Hogg Dube syndrome, 819,
821
carcinoid tumors, 837-838
chromophobe cell renal carcinoma,
824-828
chromosomal translocations, 29
classification o f renal tumors,
820-821
clear cell carcinoma
see
clear cell renal
carcinoma
collecting duct carcinoma, 833-836
detection of, 429
extrarenal rhabdoid tumor, 491
genetics and molecular biology, 818-837
hereditary, 818-819, 820
juxtaglomerular cell tumor, 838,
839
lymphoma, 844
malignant epithelial tumors, 817-818
metastasis to kidney, 844
mucinous tubular and spindle cell
carcinoma, 828, 830-831,
833
,
834
renal cell carcinoma
see
RCC (renal cell
carcinoma)
and renal cysts, 813-814
renal medullary carcinoma, 836-837
renal pelvis tumors, 427,
428
sarcoma, 844
kidneys/kidney disorders
see also
urinary tract
abscesses, 814
anatomy and histology, 812
angiomyolipoma, 814-816
benign epithelial tumors, 816-817
benign renal tumors, 814-816
congenital cysts, 813-814
diagnostic accuracy of FNA, 864-865
fine needle aspiration biopsy,
image-guided, 605
glomeruli, 812
Henle's loop, 812, 813
imaging techniques, 812
immunocytochemistry, 813
inflam m atory disorders, 814
metanephric adenoma, 817
norm al kidney, cytology of, 812-813
oncoytoma, 816
renal adenoma, 817
renal allograft, FNA of, 964-965
renal cysts, 813
xanthogranulomatous pyelonephritis,
814
Kimura's disease, 678
Klippel-Trenaunay syndrome, angiosarcoma,
485
Koehler illum ination, light optical microscopy,
1010-1012
KOH (potassium hydroxide), vagina pH, 97
koilocytes/koilocytotic cells
and human papillomavirus, 113,
114,
150, 152
koilocytotic atypia,
151
and low-grade squamous intraepithelial
lesions,
67
1106
previous page 1089 ComprehensiveCytopathology 1104p 2008 read online next page 1091 ComprehensiveCytopathology 1104p 2008 read online Home Toggle text on/off